Glyburide vs Insulin and Adverse Pregnancy Outcomes--Reply

Affiliations

¹ Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
² Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.

Comment

Wendy Camelo Castillo et al. JAMA Pediatr. 2015 Oct.

. 2015 Oct;169(10):975.

doi: 10.1001/jamapediatrics.2015.1811.

¹ Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore.
² Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.

No abstract available

Comment on

Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.
Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK Jr, Jonsson Funk M. Camelo Castillo W, et al. JAMA Pediatr. 2015 May;169(5):452-8. doi: 10.1001/jamapediatrics.2015.74. JAMA Pediatr. 2015. PMID: 25822253
Glyburide vs Insulin and Adverse Pregnancy Outcomes.
Feghali MN, Scifres CM, Caritis SN. Feghali MN, et al. JAMA Pediatr. 2015 Oct;169(10):974. doi: 10.1001/jamapediatrics.2015.1805. JAMA Pediatr. 2015. PMID: 26437011 No abstract available.
Glyburide vs Insulin and Adverse Pregnancy Outcomes.
Rezai S, Vielman M, Henderson CE. Rezai S, et al. JAMA Pediatr. 2015 Oct;169(10):974-5. doi: 10.1001/jamapediatrics.2015.1808. JAMA Pediatr. 2015. PMID: 26437012 No abstract available.